ORGO
Organogenesis Holdings Inc
1.40$
-2.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -36.6% | -195.8% | – | +83.5% | +25.8% | -282.3% | – | – | +1,180.3% | -46.4% | -249.8% | – | |
| – | +225.8% | -49.8% | -32.0% | +4.9% | +45.8% | -2.1% | -27.2% | +52.7% | +0.4% | +76.4% | -87.0% | – | |
| – | -2.1% | +1.7% | +6.7% | +5.6% | +6.6% | +16.5% | -24.5% | +20.6% | +41.1% | -15.9% | -16.1% | – | |
| – | -187.7% | – | – | – | – | – | – | – | – | – | -88.5% | – | |
| – | -44.4% | -33.2% | -15.4% | +36.6% | +30.8% | +7.9% | +0.3% | -38.6% | +108.1% | -32.4% | -65.0% | – | |
| – | -44.4% | -33.2% | -15.4% | +36.6% | +30.8% | +7.9% | +0.3% | -38.6% | +108.1% | -32.4% | -65.0% | – | |
| – | – | – | – | – | – | +0.0% | +56.3% | +100.1% | -96.6% | +1,480.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +3,623.0% | -99.5% | +1.1% | +2.8% | +2.0% | +3,158.3% | -96.5% | – | |
| – | +23.6% | +46.8% | -33.8% | -2.9% | – | -106.1% | -86.0% | +3,444.1% | -52.9% | +320.3% | -38.1% | – | |
| – | -40.8% | -371.9% | – | +293.4% | +826.6% | -162.1% | – | – | – | -107.5% | – | – | |
| – | -32.2% | -269.9% | – | +114.3% | +23.7% | -411.0% | – | – | +4,019.4% | -48.3% | -282.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.